• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOSPIRA, INC. (ICU MEDICAL, INC) PLUM; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOSPIRA, INC. (ICU MEDICAL, INC) PLUM; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 1468728
Device Problem Hole In Material (1293)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/02/2018
Event Type  malfunction  
Event Description
Small pinhole found when priming iv tubing.Primary plum set, lot # 830735h.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLUM
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
HOSPIRA, INC. (ICU MEDICAL, INC)
951 calle amanecer
san clemente CA 92673
MDR Report Key7457747
MDR Text Key106432722
Report Number7457747
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Other
Type of Report Initial
Report Date 04/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/25/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date11/01/2020
Device Model Number1468728
Device Catalogue Number1468728
Device Lot Number830735H
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA04/18/2018
Event Location Hospital
Date Report to Manufacturer04/18/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Treatment
NO OTHER THERAPIES
Patient Age35 YR
-
-